Senior Oncology Clinical Development Director

ABBVIE; Florham Park (NJ); On-site; USD 207,000 - 393,000; Full time

Benefits offered by this job

Long-term incentive programs

Comprehensive benefits package

401(k) plan

Paid time off

Job summary

AbbVie seeks a Senior Scientific Director, Oncology Clinical Development (NHL & Leukemia) in the United States. The role is full-time with a base salary range of USD 206,500 to USD 393,000 yearly.

The position leads cross-functional teams to design, analyze, and report pivotal clinical data for the product’s development plan. Responsibilities include ownership of study design, timelines, safety/efficacy data interpretation, and regulatory submissions, while fostering collaboration with medical

Qualifications

• Bachelor’s degree in sciences; MS/PhD preferred.
• 8+ years of relevant clinical trial experience.
• Ability to lead complex clinical programs independently.
• Strong leadership and cross-functional collaboration skills.
• Excellent oral and written English communication.

Responsibilities

• Oversees design, analysis, interpretation and reporting of scientific content for protocols and regulatory submissions.
• Leads multiple clinical development programs within oncology, ensuring timelines and study integrity.
• Provides clinical development expertise to governance forums and cross-functional teams.
• Represents AbbVie in external meetings and maintains regulatory compliance.

Skills

Leadership

Cross-functional collaboration

Regulatory knowledge

Oral and written communication

Strategic thinking

Influence

Education

Bachelor's degree in the sciences

MS or PhD preferred

Job description

AbbVie seeks a Senior Scientific Director, Oncology Clinical Development (NHL & Leukemia) in the United States. The role is full-time with a base salary range of USD 206,500 to USD 393,000 yearly.

The position leads cross-functional teams to design, analyze, and report pivotal clinical data for the product’s development plan. Responsibilities include ownership of study design, timelines, safety/efficacy data interpretation, and regulatory submissions, while fostering collaboration with medical